Type to search

Heartseed Raises $37 Million in Series C Funding to Accelerate Development of iPSC-derived Stem Cell Therapy for Heart Failure | Pharmtech Focus
New Roche Data for Evrysdi Show Improved Motor Function in Pre-symptomatic Babies after One Year and Confirm Safety Profile in Previously Treated People with Spinal Muscular Atrophy (SMA) | Pharmtech Focus
New Data Shows AbbVie's VENCLYXTO/VENCLEXTA Fixed Duration Combination Demonstrates Sustained Progression-Free Survival in Chronic Lymphocytic Leukemia Patients after Three Years off Treatment | Pharmtech Focus